Literature DB >> 23245981

Psychiatric medications: adverse cutaneous drug reactions.

Sarah A Bliss1, Julia K Warnock.   

Abstract

Psychiatric medications are among the most widely prescribed medications in the United States. Adverse cutaneous drug reactions are associated with psychiatric medications in approximately 2% to 5% of the individuals for whom they are prescribed. Although most adverse cutaneous drug reactions associated with psychotropic medications are benign and easily treated, some can be disfiguring or life-threatening, particularly those associated with the mood stabilizers. Adverse cutaneous drug reactions associated with antidepressants, antipsychotics, and mood stabilizers are reviewed, and important issues that are of concern for the dermatologist who must consider when and how to safely discontinue a psychotropic medication in their patients are presented.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23245981     DOI: 10.1016/j.clindermatol.2011.11.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  5 in total

Review 1.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial.

Authors:  Anne C La Flamme; David Abernethy; Dalice Sim; Liz Goode; Michelle Lockhart; David Bourke; Imogen Milner; Toni-Marie Garrill; Purwa Joshi; Eloise Watson; Duncan Smyth; Sean Lance; Bronwen Connor
Journal:  BMJ Neurol Open       Date:  2020-07-09

3.  Antipsychotic-associated psoriatic rash - a case report.

Authors:  Camelia-Eugenia Bujor; Torkel Vang; Jimmi Nielsen; Ole Schjerning
Journal:  BMC Psychiatry       Date:  2017-07-04       Impact factor: 3.630

4.  Use of psychiatric drugs in Dermatology.

Authors:  Magda Blessmann Weber; Júlia Kanaan Recuero; Camila Saraiva Almeida
Journal:  An Bras Dermatol       Date:  2020-02-18       Impact factor: 1.896

5.  The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study.

Authors:  Philip Gorwood; Jacques Benichou; Nicholas Moore; Enric Álvarez Martínez; Joost Mertens; Eugenio Aguglia; Maria-Luisa Figueira; Peter Falkai; Valérie Olivier; Marine Wattez; Françoise Picarel-Blanchot; Christian de Bodinat
Journal:  Hum Psychopharmacol       Date:  2020-09-25       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.